Join Now!      Login

Whole Person Wellness Program Wellness Model
Skip Navigation Links
Health Centers
Key Services
Medicial Mistakes?
How many people each year suffer some type of preventable harm that contributes to their death after a hospital visit?
from 46,000 to 78,000
from 78,000 to 132,000
from 132,000 to 210,000
from 210,000 to 440,000

 What Doctors Don't Tell You: PARKINSON'S DISEASE 
What Doctors Don't Tell You © (Volume 7, Issue 3)
The orthodox treatment for Parkinson's disease is L-Dopa, an amino acid. But for this to work, a co-enzyme called NADH is essential. NADH is formed from one of the B vitamins called niacin, or vitamin B3 (Biochem Med Metab Biol, 1986; 36(2): 244-51).

Many Parkinsonian patients have benefited from taking niacin.Oddly enough, Parkinsonian patients being treated with L-Dopa, particularly those also given benserazide or carbidopa, run a risk of developing a niacin deficiency. Taking the two drugs can also produce deficiency of vitamin B6. Besides niacin, you may need vitamin B6 supplements, but this can cancel out the effects of L-Dopa, unless you are taking it concurrently with carbidopa (AMA Drug Evaluations, 5th ed, 1983, American Medical Association, Chicago, 1983).

A common problem with conventional L-Dopa therapy is the so called "on off" effect, where L-Dopa works better at particular times of the day than others. These fluctuations, which have been linked to the consumption of proteins, can be effectively reduced when almost all of the day's protein is taken with the evening meal (Neurology, 1989; 39: 549-52).

There's evidence that Parkinsonism is associated with a low intake of foods rich in vitamin E early in life (Arch Neurol, 1988; 45:1350-3); occasionally, a folic acid deficiency may cause Parkinson's disease (J Neurol Neurosurg Psychiatry, 1986; 49: 920-7), as can a magnesium deficiency (Can J Neurol Sci, 1989, 16 (3) 310-4).

Taking an excessive amount of manganese as a nutritional supplement may lead to Parkinson's, as can too high levels of mercury or aluminium (Neuroepidem, 1989; 8(3):128-41).

Copper concentrations in the cerebrospinal fluid are often significantly higher in sufferers than in the normal population. In one study, copper concentrations related both to the severity and the rate of progression (Lancet, 1987, ii: 238-41). (Homoeopathic drainage, pioneered in France, can be used to quickly reduce copper concentrations.)

The enzyme that converts the amino acid L-tyrosine to L-Dopa is less active in Parkinsonian patients. As iron activates this enzyme, taking iron supplementation has had impressive results in at least one study (J Neurol Trans, 1986; 67:287-92). But to confuse matters further, Parkinsonian patients are known to have raised iron levels in a portion of their brains, which appears to aggravate the disease process (Can J Neurol Sci, 1990; 17(3): 286-91).

The most successful herbal treatment by far is the root of the deadly nightshade (Atropa belladonna). Used in the treatment of post encephalitic and post influenzal Parkinsonism after the great influenza epidemic in the early part of this century, the treatment was closely investigated and the astonishing results published (R F Weiss, Herbal Medicine, Ab Arcanum, Gothenburg, 1988). More recent research has shown that the total extract of the Belladonna root has significant benefits (Arzneimittel Forschung, 1971, 21(4):528). In the former USSR one successful study was conducted on the treatment of Parkinsonism with Bulgarian Belladonna root preparations (Zhurnal Nevro patologii i Psikhiatrii Imeni S S-Kors-akova, 1966; 66 (5): 698-703).

In Ayruvedic Medicine, material derived from the plant Macuna pruriens is often used on patients with Parkinson's disease, and one study of 60 patients found it to be effective. Adverse effects, mainly affecting the gut, were very mild (J Alt & Comp Med: Res on Paradigm Pract & Policy, 1995; 1 (3): 249-55).

The most impressive research on non orthodox treatment of Parkinson's concerns the use of L-methionine. WDDTY panel list Melvyn Werbach knows of several studies showing that L-methionine is as effective as L-Dopa after three weeks in people with previously untreated Parkinson's disease (Rev Neurol [Paris],1982; 138 (4): 297-303). It also brought about further improvement in Parkinsonian patients who'd reached a plateau in their orthodox treatment (South Med J, 1984; 77: 1577).

 Comments Add your comment 

 About The Author
What Doctors Don't Tell You What Doctors Don’t Tell You is one of the few publications in the world that can justifiably claim to solve people's health problems - and even save lives. Our monthly newsletter gives you the facts you won't......more
 From Our Friends
Popular & Related Products
Popular & Featured Events
Error Reading Event Calendar
Stevia Products & Info
Dimensions of Wellness
Wellness, Self Responsibility, Love, dimension!

Home       Wellness       Health A-Z       Alternative Therapies       Find a Practitioner       Wellness Inventory
Healthy Kitchen       Healthy Woman       Healthy Man       Healthy Child       Healthy Aging       Wellness Center       Nutrition Center       Fitness Center
Stevia      Discount Lab Tests      First Aid      Global Health Calendar      Healthy Products       Privacy Policy     Contact Us
Disclaimer: The information provided on HealthWorld Online is for educational purposes only and IS NOT intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek professional medical advice from your physician or other qualified healthcare provider with any questions you may have regarding a medical condition.
Are you ready to embark on a personal wellness journey with our whole person approach?
Learn More/Subscribe
Are you looking to create or enhance a culture of wellness in your organization?
Learn More
Do you want to become a wellness coach?
Learn More
Free Webinar